The treatment of Raynaud's phenomenon.
Seibold
J R
JR
Clinical Pharmacology Unit, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019.
Allegar
N E
NE
D001521:Behavior Therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D011928:Raynaud Disease / Q000628:therapy*; D013562:Sympathectomy
D002121:Calcium Channel Blockers; D011453:Prostaglandins; D007650:Ketanserin